- Home
- SGHT vs ZVIA Comparison
SGHT vs ZVIA Comparison
Compare SGHT & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- ZVIA
- Stock Information
- Founded
- SGHT 2011
- ZVIA 2007
- Country
- SGHT United States
- ZVIA United States
- Employees
- SGHT N/A
- ZVIA N/A
- Industry
- SGHT Medical Specialities
- ZVIA Beverages (Production/Distribution)
- Sector
- SGHT Health Care
- ZVIA Consumer Staples
- Exchange
- SGHT Nasdaq
- ZVIA Nasdaq
- Market Cap
- SGHT 193.2M
- ZVIA 193.4M
- IPO Year
- SGHT 2021
- ZVIA 2021
- Fundamental
- Price
- SGHT $7.17
- ZVIA $2.52
- Analyst Decision
- SGHT Buy
- ZVIA Buy
- Analyst Count
- SGHT 8
- ZVIA 5
- Target Price
- SGHT $4.93
- ZVIA $4.89
- AVG Volume (30 Days)
- SGHT 247.0K
- ZVIA 806.1K
- Earning Date
- SGHT 11-06-2025
- ZVIA 11-05-2025
- Dividend Yield
- SGHT N/A
- ZVIA N/A
- EPS Growth
- SGHT N/A
- ZVIA N/A
- EPS
- SGHT N/A
- ZVIA N/A
- Revenue
- SGHT $76,052,000.00
- ZVIA $162,849,000.00
- Revenue This Year
- SGHT N/A
- ZVIA $6.44
- Revenue Next Year
- SGHT $12.04
- ZVIA $6.68
- P/E Ratio
- SGHT N/A
- ZVIA N/A
- Revenue Growth
- SGHT N/A
- ZVIA 6.17
- 52 Week Low
- SGHT $2.03
- ZVIA $1.86
- 52 Week High
- SGHT $8.06
- ZVIA $4.99
- Technical
- Relative Strength Index (RSI)
- SGHT 74.25
- ZVIA 49.46
- Support Level
- SGHT $4.86
- ZVIA $2.54
- Resistance Level
- SGHT $8.06
- ZVIA $2.78
- Average True Range (ATR)
- SGHT 0.43
- ZVIA 0.14
- MACD
- SGHT 0.19
- ZVIA 0.02
- Stochastic Oscillator
- SGHT 70.31
- ZVIA 41.41
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.